Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts

被引：61

作者：

Caraballo, P. J. ^{[1
,2
]}

Bielinski, S. J. ^{[3
]}

Sauver, J. L. St. ^{[3
,4
]}

Weinshilboum, R. M. ^{[5
,6
,7
]}

机构：

[1] Mayo Clin, Div Gen Internal Med, Dept Med, Rochester, MN 55905 USA

[2] Mayo Clin, Off Informat & Knowledge Management, Rochester, MN 55905 USA

[3] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA

[4] Mayo Clin, Ctr Sci Hlth Care Delivery, Rochester, MN USA

[5] Mayo Clin, Div Clin Pharmacol, Dept Mol Pharmacol, Rochester, MN USA

[6] Mayo Clin, Dept Expt Therapeut & Med, Rochester, MN USA

[7] Mayo Clin, Ctr Individualized Med, Rochester, MN USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 102卷 / 02期

关键词：

IMPLEMENTATION CONSORTIUM GUIDELINES; PERSONALIZED MEDICINE; HEALTH RECORD; GENOMIC MEDICINE; DRUG; DESIGN; MODEL; CHALLENGES; PHYSICIANS; UNIVERSITY;

D O I：

10.1002/cpt.707

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Advances in pharmacogenomics (PGx) have the potential to transform healthcare by allowing precision medicine to become a reality. However, PGx knowledge is new, complex, and evolving, and relying on the cognition of clinicians alone is insufficient for clinical implementation. Integrating clinical decision support (CDS) tools in the electronic health record (EHR) is critical for translating PGx into clinical practice. Herein, we review current strategies to implement PGx using EHR-CDS functionalities.

引用

页码：254 / 264

页数：11

共 67 条

[1]

[Anonymous], TABL PHARM BIOM DRUG

[2]

[Anonymous], GENET MED

[3]

[Anonymous], CLIN TRANSL SCI

[4]

[Anonymous], 2016, GUIDELINES USE ANTIR

[5]

[Anonymous], GENETIC TESTING REGI

[6]

[Anonymous], MED ERROR REPORTS

[7]

[Anonymous], DIABETES CARE

[8]

[Anonymous], GENET MED

[9]

Aspden P., 2006, PREVENTING MEDICATIO

[10]

Beaulieu M, 2010, PHARMACOGENOMICS, V11, P1573, DOI [10.2217/pgs.10.145, 10.2217/PGS.10.145]

← 1 2 3 4 5 6 7 →